Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer.
about
Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-AnalysisS-1-based vs non-S-1-based chemotherapy in advanced gastric cancer: a meta-analysisS-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer.Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination.A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer.
P2860
Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Phase II study of biweekly doc ...... t for advanced gastric cancer.
@en
Phase II study of biweekly doc ...... t for advanced gastric cancer.
@nl
type
label
Phase II study of biweekly doc ...... t for advanced gastric cancer.
@en
Phase II study of biweekly doc ...... t for advanced gastric cancer.
@nl
prefLabel
Phase II study of biweekly doc ...... t for advanced gastric cancer.
@en
Phase II study of biweekly doc ...... t for advanced gastric cancer.
@nl
P2093
P2860
P1476
Phase II study of biweekly doc ...... t for advanced gastric cancer.
@en
P2093
Chikara Kunisaki
Fumihiko Kito
Hidetaka A Ono
Hirochika Makino
Hirotoshi Akiyama
Itaru Endo
Jun Kimura
Kunio Kameda
Masazumi Takahashi
Ryo Takagawa
P2860
P2888
P304
P356
10.1007/S00280-010-1433-7
P577
2010-08-28T00:00:00Z